Arkolith/Insider Trading/ZIVO/Form 4

Yaldoo Laith L

Director, 10% OwnerZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Oct 6, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 2, 2025Grant(A)926$10.20$9K926

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-25-011515) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML